AI Stock Picks — NASDAQ 100

Wednesday, October 28, 2026  ·  Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days

Today's Market Mood

Neutral  Normal choppiness · VIX 17.1

The NASDAQ 100 is showing a sharp rotation: mega-cap AI/semiconductor names (Meta, Alphabet, NVIDIA, AMD, Lam Research, KLA, Applied Materials, memory/storage) are in steep 30-day drawdowns, while defensive and value-tilted constituents in staples, utilities, healthcare, and select industrials/security-software names are pushing toward 52-week highs on sustained multi-week strength. Index-level breadth is narrow, so near-term 5%+ setups are concentrated outside the AI-infrastructure complex.

Rotation out of AI/semiconductor momentum into defensive and value sectorsMega-cap tech earnings-driven weakness dragging index sentiment (Meta, Alphabet, NVIDIA, AMD)Staples, utilities, healthcare and select industrials grinding toward 52-week highsSecurity software (CrowdStrike, Palo Alto) showing sharp 5-day bouncesBroad semiconductor equipment/memory complex (Lam Research, KLA, Applied Materials, Teradyne, SanDisk, Seagate) in a severe multi-week drawdown with little sign of stabilization

Today's Actionable List

Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.

0 of 3
0%
94 · 155.3%
155.3% / 60%
0 of 20
RankStockActionSizeEntry → TargetNotes
#1 GEHC SKIP — $75.77 → $79.64
stop $69.10
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#2 REGN SKIP — $809.97 → $851.48
stop $742.74
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#3 CRWD SKIP — $264.87 → $278.11
stop $240.50
 Half-Kelly sizes this at 0% — the odds carry no edge worth capital.

Already open: EMR (to Nov 1), ALW.L (to Nov 1), MSFT (to Nov 4), AMZN (to Nov 8), PYPL (to Nov 8), HUM (to Nov 11), TJX (to Nov 11), SHOP (to Nov 11), MA (to Nov 12), BNZL.L (to Nov 12), LIN (to Nov 13), GILD (to Nov 14) … and 82 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.

Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.

Behind the scenes: how each AI analyst did
Aria
7 picks
Blaze
6 picks
Nova
1 pick
Orion
5 picks
Quinn
5 picks

3 Stock Picks

Diversification filter applied: 1 pick removed due to high same-sector price correlation with a higher-ranked pick (PANW), avoiding concentrated sector exposure.
Sector concentration cap applied: 1 lower-ranked pick removed to keep at most 2 picks per sector (ISRG), so the final list isn't over-concentrated in one sector.
#1 GEHCGE HealthCare Technologies Inc.
5/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals  ⚠ Earnings in Window
Moderate conviction · 56%

GE HealthCare makes medical imaging machines and diagnostic equipment used by hospitals worldwide. The company just reported earnings today that beat expectations and raised its full-year outlook, sending the stock up sharply, and it's still well below its 52-week high so there may be more room to run. The key risk is that the stock already jumped a lot today, so some of the good news may already be reflected in the price.

Stop-loss$69.10-8.8%
Today's price$75.77
Target$79.64+5.1%
Agents estimate: $79.71 (+0.1% vs target)
If you invested $1,000
▲$1,051 if the target hits (+5.1%)
▼$912 if the stop-loss is hit (-8.8%)
The AI puts the chance of the win case at 56%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • RSI at 72.28 is in overbought territory, and price at $75.77 is pressing right against the upper Bollinger Band of $74.70 — a classic exhaustion setup after a single-day +13.46% gap, raising odds of mean reversion rather than continuation.
  • The 5-day momentum of only 3.61% versus the 30-day return of 13.13% shows nearly all the gain came in today's single earnings-gap session, not a sustained trend the bulls' MACD/OBV framing implies.
Show the detailed analysis

Calibrated probability: 56% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.

Trade math

0.6:1
63%
+0.2%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
60%
Medium
Blaze
78%
Very High
Nova
68%
High
Orion
60%
High
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#2 REGNRegeneron Pharmaceuticals, Inc.
4/5 Agents Agree  Risk 5/10  ⚠ Conflicting Signals  ⚠ Earnings in Window
Moderate conviction · 56%

Regeneron is a biotech company best known for eye and immune-disease drugs like EYLEA. The stock is in a strong uptrend, trading above both its short- and long-term moving averages while beating the broader market. The big risk is that the company reports earnings in just two days, and biotech stocks can swing sharply in either direction on earnings news.

Stop-loss$742.74-8.3%
Today's price$809.97
Target$851.48+5.1%
Agents estimate: $852.50 (+0.1% vs target)
If you invested $1,000
▲$1,051 if the target hits (+5.1%)
▼$917 if the stop-loss is hit (-8.3%)
The AI puts the chance of the win case at 56%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Volume is thin at 289,417 shares versus the stock's scale, and OBV sits at just 280,978 — a fraction of GEHC's or CRWD's OBV — meaning the 'clean volume confirmation' claim rests on comparatively light participation that could reverse easily.
  • Price at $809.97 is already testing the upper Bollinger Band ($838.52 is the ceiling but the middle band is $774.90, well below current price), suggesting the move is stretched above its mean rather than offering fresh room.
Show the detailed analysis

Calibrated probability: 56% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.

Trade math

0.6:1
62%
+0.4%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
61%
High
Nova
—
—
No recent catalyst was found in the news, and the upcoming earnings report in 2 days is an unresolved event, not a proven positive catalyst yet.
Orion
66%
High
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha
#3 CRWDCrowdStrike Holdings, Inc.
4/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals
Moderate conviction · 56%

CrowdStrike sells cloud-based software that protects companies' computers from cyberattacks. The stock has surged sharply over the past week and is trading comfortably above its key moving averages, backed by strong trading volume. The main risk is the CEO has been selling shares frequently in recent weeks, and after such a fast run-up a pullback is always possible.

Stop-loss$240.50-9.2%
Today's price$264.87
Target$278.11+5.0%
If you invested $1,000
▲$1,050 if the target hits (+5.0%)
▼$908 if the stop-loss is hit (-9.2%)
The AI puts the chance of the win case at 56%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • The 30-day return is a mere 2.17% while the 5-day return is 10.67%, meaning almost the entire 'momentum' thesis is a single sharp spike in the last week, not a durable trend — raising the risk this is a post-earnings pop prone to giving back gains.
  • Price at $264.87 is closing in on the upper Bollinger Band of $288.18 but note the ATR of 12.29 is large relative to the $264.87 price, implying high volatility that could just as easily whip the stock back toward the $256.11 mid-band inside the 30-day window.
Show the detailed analysis

Calibrated probability: 56% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.

Trade math

0.5:1
65%
+0.3%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
72%
Very High
Blaze
74%
Very High
Nova
—
—
No company-specific catalyst showed up in recent news, and the CEO has been steadily selling shares almost weekly this month.
Orion
63%
High
Quinn
60%
Medium

Data Sources

Yahoo FinanceFinvizMarketWatchSeeking Alpha

Retail Investor Execution Guide

This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by November 27, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.

Step-by-Step Action Plan

  1. Act within one trading day. Prices are freshest now. The longer you wait, the more the entry price drifts away from what the agents analysed.
  2. Verify the entry price. Check the live price before buying. If a stock has already moved more than 3% above the Current Price shown in the report, skip it or wait for a pullback — the risk/reward has shifted.
  3. Use limit orders, not market orders. Set your buy limit at or below the Current Price shown. Chasing with a market order gives brokers and algorithms an advantage over you.
  4. Set your stop-loss immediately after buying. Use the Max Downside % on each pick card as your hard exit level. If the price falls to that level, sell without hesitation — the trade thesis is broken.
  5. Set a take-profit at the Target Price. Place a limit sell order at the Target Price shown. When it fills, the trade is done — resist the urge to hold for more.
  6. Exit all positions by November 27, 2026. This is your hard deadline. If a stock has not hit its target by then, exit anyway. Holding past the window turns a short-term trade into an unsupervised long-term position.
  7. Never add to a losing position. If your stop-loss is hit, exit completely. Averaging down turns a small, controlled loss into a potentially large one.

Position Sizing by Conviction Tier

Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.

Agents Agreeing What It Means Max Allocation Per Pick
5/5 Highest conviction — all five independent analytical checks passed Up to 10%
4/5 Very high conviction — four of five independent checks aligned Up to 8%
3/5 High conviction — three agents independently agreed Up to 6%
2/5 Moderate conviction — two agents independently agreed Up to 4%
1 Agent Speculative — solo pick, admitted only at Very High confidence Up to 2%

The Three Exit Rules

These picks are generated by AI agents for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Probability estimates reflect the agents' analytical models — they are not guarantees of any outcome. Past results are not indicative of future performance. Markets can and do move against even well-researched trades. Always conduct your own research, and consider seeking advice from a licensed financial adviser before placing any orders. Never invest money you cannot afford to lose.

Understanding the Numbers

A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.

AI Conviction Meter
Estimated probability of hitting the target, shown as a 5-bar gauge
The filled bars and label translate the AI's probability estimate into plain language: 75%+ is Very strong, 60–74% Strong, 50–59% Moderate, below 50% Cautious. Where enough past picks have been resolved, the probability is calibrated against the AI's real track record.
e.g. "Moderate conviction · 58%" — the AI thinks this trade works slightly more often than a coin flip.
✓ More filled bars = more confidence — but even Very strong picks fail sometimes; always size positions accordingly.
If You Invested $1,000
$1,000 × (1 + Target Gain ÷ 100)  /  $1,000 × (1 + Max Downside ÷ 100)
The same Target Gain and Max Downside percentages expressed in concrete money terms for a $1,000 position — what you'd have if the target hits versus if your stop-loss is triggered.
e.g. +10% target and −12.3% stop → $1,100 on a win, $877 on a stopped-out loss.
✓ Scales linearly — a $500 position sees half these amounts, a $2,000 position double.
Current Price
Market price at time of analysis
The stock's price when this report was generated. All other figures on the card are calculated from this reference point.
e.g. $215.20 — check the live price before placing an order; if it has moved more than ~3%, re-evaluate the risk/reward.
✓ No positive/negative distinction — it is simply your cost basis.
Target Price
Current Price × (1 + Target Gain ÷ 100)
The price the agents project the stock could reach within the time window. This is your take-profit level — place a limit sell order here after buying.
e.g. $215.20 × 1.085 = $233.49 target on an 8.5% pick.
✓ Always above Current Price — this tool only selects upside candidates.
Target Gain
(Target Price − Current Price) ÷ Current Price × 100
The percentage return you would earn if the stock hits its Target Price from your entry. Set by the run parameters — every pick in this report targets the same percentage.
e.g. +8.5% means a $100 stock has a $108.50 target; a $500 stock has a $542.50 target.
✓ Always positive — picks are upside-only. A larger % means a bigger move is required.
Max Downside
Estimated stop-loss level, as % below entry
The worst-case loss the agents estimated if the thesis fails — based on key support levels and recent volatility. Use this as your hard stop-loss. If the price falls to this level, exit immediately; the trade thesis is broken.
e.g. −12.0% means: if you bought at $100, sell if it drops to $88.00.
⚠ Always negative. A smaller magnitude (e.g. −5%) = tighter risk. A larger magnitude (e.g. −20%) = more room to fall before you exit — riskier.
Reward : Risk
Target Gain ÷ |Max Downside|
How much you could gain for every dollar you are risking. A ratio of 2.0:1 means you stand to make $2 for every $1 at risk. Higher is better.
e.g. 8.5% gain ÷ 12% downside = 0.7:1 (unfavourable). 10% gain ÷ 5% downside = 2.0:1 (good).
✓ ≥ 2.0:1 is strong. ⚠ < 1.0:1 means you are risking more than you could gain — approach with caution.
Breakeven Win Rate
|Max Downside| ÷ (Target Gain + |Max Downside|) × 100
The minimum percentage of trades at this reward:risk that must succeed for you to break even over time — regardless of how good your stock picking is.
e.g. 12 ÷ (8.5 + 12) = 59% — you need roughly 6 in 10 trades to win just to avoid losing money.
✓ Lower is better — ≤ 35% means even a poor win rate is survivable. ⚠ ≥ 55% means you need most trades to work out.
Expected Value
(Probability% × Target Gain%) + ((1 − Probability%) × Max Downside%)
The average return per trade if the AI's probability estimate is accurate over many similar trades. A positive Expected Value means the trade has a mathematical edge; a negative value means the math works against you on average, even if you sometimes win.
e.g. 65% × +8.5% + 35% × −12% = +1.3% EV. Over 100 similar trades you would expect an average gain of 1.3% per trade.
✓ Positive = edge in your favour over many trades. ⚠ Negative = the math loses money on average — even if individual wins feel good. Note: EV is only as reliable as the probability estimate.
Suggested Allocation
half-Kelly: (Probability ÷ |Max Downside| − (1 − Probability) ÷ Target Gain) ÷ 2, capped at 10%
The Kelly criterion computes the portfolio fraction that maximises long-run growth for a bet with these odds; half-Kelly is the standard hedge against the probability estimate being too optimistic. Uses the calibrated probability where available. 0% means the math sees no edge worth sizing; — means it couldn't be computed.
e.g. 57% probability, +10% target, −13% downside → Kelly ≈ 8.5% of portfolio, half-Kelly ≈ 4.2%.
Generic sizing guidance only — not personal investment advice. Position sizing must reflect your own portfolio, risk tolerance and circumstances.
Every stock Scout considered — and why each was discarded

Scout scanned 101 NASDAQ 100 constituents and short-listed 24 candidates for deep analysis by the five analysts. Here is what happened to each one.

  • ROPRoper Technologies, Inc.Already held
    Scout: Standout momentum: +10% over 5 days and +23.5% over 30 days while only ~4% off its 52-week high — strongest sustained uptrend in the index.
    Already held: a position opened 2026-10-27 runs until 2026-11-26 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CSXCSX CorporationAlready held
    Scout: Consistent strength across windows (+7% 5-day, +11% 30-day) and just ~3% from its 52-week high, signaling a durable breakout.
    Already held: a position opened 2026-10-22 runs until 2026-11-21 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ADIAnalog Devices, Inc.Already held
    Scout: Rare analog-chip name bucking the semiconductor selloff, up nearly 5% in 5 days and 7.6% in 30 days, close to its highs.
    Already held: a position opened 2026-10-27 runs until 2026-11-26 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • FANGDiamondback Energy, Inc.Dropped at merge
    Scout: Energy strength with +12% over 30 days and only ~4% below its 52-week high, aided by firmer crude sentiment.
    Only Aria selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: High, 65% raw (56% after calibration)).
  • AMGNAmgen Inc.Already held
    Scout: Biotech large-cap sitting under 1% from its 52-week high with steady 5-day and 30-day gains, suggesting continuation potential.
    Already held: a position opened 2026-10-15 runs until 2026-11-14 (17 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • GILDGilead Sciences, Inc.Already held
    Scout: Within ~1% of its 52-week high with positive momentum on both the 5-day and 30-day windows — a defensive healthcare name still trending up.
    Already held: a position opened 2026-10-15 runs until 2026-11-14 (17 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • KDPKeurig Dr Pepper Inc.Already held
    Scout: Consumer staple pressing toward a new high (within 1.7%), up over 10% in the past month with steady recent follow-through.
    Already held: a position opened 2026-10-15 runs until 2026-11-14 (17 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CCEPCoca-Cola Europacific Partners PLCAlready held
    Scout: Staple beverage name near its 52-week high (~3% away) with consistent 5-day and 30-day gains.
    Already held: a position opened 2026-10-15 runs until 2026-11-14 (17 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • SNPSSynopsys, Inc.Dropped at merge
    Scout: Design-software name showing accelerating momentum: +6% 5-day on top of +14.5% 30-day, decoupled from the broader chip-equipment selloff.
    Only Blaze selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: Very High, 74% raw (60% after calibration)).
  • TXNTexas Instruments IncorporatedAlready held
    Scout: Analog chipmaker with strong recent acceleration (+7.8% 5-day, +10.3% 30-day), holding up far better than peers in equipment/memory.
    Already held: a position opened 2026-10-26 runs until 2026-11-25 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • SBUXStarbucks CorporationDropped at merge
    Scout: Turnaround momentum building: +4.3% over 5 days and +8.5% over 30 days with room before resistance at its 52-week high.
    Qualified on merit but ranked #6, outside the 5-pick limit for this run.
  • EXCExelon CorporationAlready held
    Scout: Utility benefiting from a defensive rotation, up almost 4% in 5 days and nearly 11% over 30 days.
    Already held: a position opened 2026-10-26 runs until 2026-11-25 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • XELXcel Energy Inc.Already held
    Scout: Steady utility uptrend, +11.5% over 30 days, benefiting from capital flowing into rate-sensitive defensives.
    Already held: a position opened 2026-10-16 runs until 2026-11-15 (18 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • AEPAmerican Electric Power Company, Inc.Already held
    Scout: Another utility riding the defensive rotation with a consistent +8.8% 30-day gain and positive near-term follow-through.
    Already held: a position opened 2026-10-22 runs until 2026-11-21 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • LINLinde plcAlready held
    Scout: Industrial gases leader showing steady strength (+7.4% 30-day) within ~7.5% of its 52-week high.
    Already held: a position opened 2026-10-14 runs until 2026-11-13 (16 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • GEHCGE HealthCare Technologies Inc.Picked #1
    Scout: Strong recent acceleration with +9.8% over 5 days and +13.5% over 30 days, indicating fresh buying interest.
    Made the final report at #1.
  • WMTWalmart Inc.Already held
    Scout: Mega-cap retailer trending higher (+9.2% 30-day) as investors rotate into defensive consumer names.
    Already held: a position opened 2026-10-15 runs until 2026-11-14 (17 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • REGNRegeneron Pharmaceuticals, Inc.Picked #2
    Scout: Biotech holding a steady uptrend, +7.7% over 30 days and within 6% of its 52-week high.
    Made the final report at #2.
  • CRWDCrowdStrike Holdings, Inc.Picked #3
    Scout: Sharp 5-day bounce of nearly 11% suggests renewed buying in security software even as broader tech pulls back.
    Made the final report at #3.
  • PANWPalo Alto Networks, Inc.Diversification filter
    Scout: Strongest 5-day move in the index at +13.7%, indicating a fresh catalyst-driven breakout in cybersecurity.
    Dropped by diversification filter: 0.92 30-day daily-return correlation with CRWD (both in Technology).
  • TSLATesla, Inc.Already held
    Scout: Positive across both windows (+4.2% 5-day, +12.6% 30-day) with enough volatility and volume to realistically move 5%+ further.
    Already held: a position opened 2026-10-27 runs until 2026-11-26 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • MARMarriott International, Inc.Already held
    Scout: Within ~4% of its 52-week high with a healthy +9.6% 30-day gain despite a minor recent pullback.
    Already held: a position opened 2026-10-19 runs until 2026-11-18 (22 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • MNSTMonster Beverage CorporationAlready held
    Scout: Consumer staple up over 9% in 30 days, trading close to its highs despite a small recent dip.
    Already held: a position opened 2026-10-19 runs until 2026-11-18 (22 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ISRGIntuitive Surgical, Inc.Passed over
    Scout: Medtech name with solid dual-window momentum (+4.1% 5-day, +7.4% 30-day) showing renewed strength after a prior drawdown.
    Nova: No company-specific catalyst was found in recent news, and the next earnings report is nearly three months away, well outside the holding period.
    Quinn: Trading volume is diverging from price and the stock remains below its 200-day average, pulling the quantitative score down to the minimum floor.

Agent Analytical Approaches

Aria

Momentum & Technical

Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.

Blaze

Fundamental & Earnings

Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).

Nova

News Catalyst & Event-Driven

Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.

Orion

Macro & Sector Rotation

Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.

Sage

Devil's Advocate

Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.

Quinn

Quantitative / Statistical

Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.